4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000084
Chief Commercial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Edwards Larry Todd · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-24 | Grant or award : show line 1 in the form | +100,000 | 100,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-24 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +20,000 | 20,000 | D |
Loading xslF345X06/form4.xml…